Quantigic® Solutions LLC

Background

Quantigic® Solutions LLC, also known as Vynance Technologies LLC, is a privately held company specializing in quantitative modeling. Founded in 2017, the company focuses on developing proprietary risk models for equities and exchange-traded funds (ETFs), as well as providing consulting services for the analysis of business, financial, and scientific data.

Key Strategic Focus

Quantigic® Solutions offers a suite of products and services tailored to quantitative trading and risk management:

Custom Risk Models for Equities: Proprietary models designed to meet specific quantitative trading requirements.

ETF Risk Models: Innovative risk models for ETFs developed using the company's unique technology.

Consulting Services: Quantitative solutions for analyzing business, financial, and scientific data.

These offerings are aimed at enhancing risk assessment and decision-making processes for clients in the financial sector.

Financials and Funding

In 2021, Quantigic® Solutions received a Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) totaling $275,987 for a project titled "Cancer Diagnostic Tool Using Cancer Genomic Signatures to Determine Cancer Type." The company has not reported any additional funding rounds or venture capital investments.

Pipeline Development

The company's notable project involves the development of a cancer diagnostic tool utilizing genomic signatures to identify cancer types. This initiative is part of their broader effort to apply quantitative modeling techniques to healthcare and biomedical research.

Technological Platform and Innovation

Quantigic® Solutions distinguishes itself through its proprietary technologies and methodologies:

Proprietary Risk Models: Custom-developed models for equities and ETFs, tailored to specific client needs.

Quantitative Analysis Techniques: Advanced methodologies for analyzing complex datasets across various domains, including finance and healthcare.

Leadership Team

The company is led by Co-founder and CEO Zura Kakushadze, Ph.D. Dr. Kakushadze earned his Ph.D. in theoretical physics from Cornell University at the age of 23. He has held positions as a Postdoctoral Fellow at Harvard University and Assistant Professor at the C.N. Yang Institute for Theoretical Physics at Stony Brook University. His industry experience includes roles as Director at RBC Capital Markets, Managing Director at WorldQuant, and Executive Vice President at Revere Data (now part of FactSet). Dr. Kakushadze has over 17 years of experience in quantitative trading and finance, with more than 130 publications in fields such as physics, finance, and cancer research.

Competitor Profile

While specific competitors of Quantigic® Solutions are not detailed in the available information, the company operates in the quantitative modeling and risk assessment sector, which includes various firms specializing in financial analytics and consulting services.

Strategic Collaborations and Partnerships

Quantigic® Solutions has engaged in collaborative research efforts, notably receiving an NSF SBIR award for developing a cancer diagnostic tool. This indicates a strategic direction towards integrating quantitative modeling with biomedical research.

Operational Insights

The company's focus on proprietary risk models and quantitative analysis positions it to offer specialized solutions in financial risk management and data analysis. Its involvement in healthcare-related projects suggests a diversification strategy leveraging its quantitative expertise.

Strategic Opportunities and Future Directions

Quantigic® Solutions is poised to expand its impact by continuing to develop innovative quantitative models and exploring applications in diverse fields such as healthcare. Leveraging its expertise in quantitative analysis, the company aims to address complex challenges across various industries.